LianBio (NASDAQ:LIAN) Trading Down 4% – What’s Next?

LianBio (NASDAQ:LIAN)’s stock price dropped 4% during trading on Tuesday . The stock traded as low as $0.41 and last traded at $0.42. Approximately 32,698 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 1,037,083 shares. The stock had previously closed at $0.43.

LianBio Price Performance

The company’s 50-day moving average price is $0.34 and its two-hundred day moving average price is $0.26. The company has a market capitalization of $44.95 million, a P/E ratio of -0.51 and a beta of 0.23.

About LianBio

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus.